289 related articles for article (PubMed ID: 26122000)
1. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.
Wang LY; Ghossein R; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Thyroid; 2015 Sep; 25(9):993-8. PubMed ID: 26122000
[TBL] [Abstract][Full Text] [Related]
2. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
[TBL] [Abstract][Full Text] [Related]
4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
5. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Kwon JS; Lim J; Shen WT; Gosnell JE; Khanafshar E; Duh QY; Suh I
Ann Surg Oncol; 2016 May; 23(5):1446-51. PubMed ID: 26628431
[TBL] [Abstract][Full Text] [Related]
6. Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome.
Radowsky JS; Howard RS; Burch HB; Stojadinovic A
Thyroid; 2014 Feb; 24(2):241-4. PubMed ID: 23713855
[TBL] [Abstract][Full Text] [Related]
7. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
8. Operative management of locally advanced, differentiated thyroid cancer.
Wang LY; Nixon IJ; Patel SG; Palmer FL; Tuttle RM; Shaha A; Shah JP; Ganly I
Surgery; 2016 Sep; 160(3):738-46. PubMed ID: 27302105
[TBL] [Abstract][Full Text] [Related]
9. Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome.
Hu A; Clark J; Payne RJ; Eski S; Walfish PG; Freeman JL
Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):644-9. PubMed ID: 17638775
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
11. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation.
Hong CM; Ahn BC; Park JY; Jeong SY; Lee SW; Lee J
Ann Nucl Med; 2012 May; 26(4):311-8. PubMed ID: 22311415
[TBL] [Abstract][Full Text] [Related]
13. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
Watanabe K; Igarashi T; Uchiyama M; Ojiri H
Ann Nucl Med; 2020 Dec; 34(12):920-925. PubMed ID: 32940889
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma.
Park SY; Kim HI; Kim JH; Kim JS; Oh YL; Kim SW; Chung JH; Jang HW; Kim TH
Br J Surg; 2018 Aug; 105(9):1155-1162. PubMed ID: 29663333
[TBL] [Abstract][Full Text] [Related]
15. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
17. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
Abraham E; Roshan D; Tran B; Wykes J; Campbell P; Ebrahimi A
J Surg Oncol; 2019 Nov; 120(6):1016-1022. PubMed ID: 31452204
[TBL] [Abstract][Full Text] [Related]
18. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
19. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
20. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
